ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 2 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,144 | -99.9% | 54,901 | -10.1% | 0.00% | 0.0% |
| Q2 2022 | $861,000 | +164.1% | 61,099 | +901.6% | 0.00% | – |
| Q4 2020 | $326,000 | -94.5% | 6,100 | -95.8% | 0.00% | -100.0% |
| Q3 2020 | $5,930,000 | -57.2% | 143,761 | -49.8% | 0.01% | -65.4% |
| Q2 2020 | $13,869,000 | +894.9% | 286,134 | +767.1% | 0.03% | +550.0% |
| Q1 2020 | $1,394,000 | -95.0% | 33,000 | -94.9% | 0.00% | -93.8% |
| Q4 2019 | $27,689,000 | – | 647,248 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |